SMS PHARMACEUTICALS Q2 FY25 Results
SMS PHARMACEUTICALS has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 196.75 Cr
- Quarter-on-Quarter (QoQ) Change: 19.64% (Previous Quarter: Rs. 164.45 Cr )
- Year-on-Year (YoY) Change: 18.07% (Same Quarter Last Year: Rs. 166.64 Cr )
Profitability Metrics
- Net Profit: Rs. 14.10 Cr
- QoQ Profit Change: -14.44% (Previous Quarter: Rs. 16.48 Cr )
- YoY Profit Change: 20.25% (Same Quarter Last Year: Rs. 11.73 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 1.69
- QoQ EPS Change: -13.33% (Previous Quarter: Rs. 1.95)
- YoY EPS Change: 21.58% (Same Quarter Last Year: Rs. 1.39)
Performance Summary
Strong
SMS PHARMACEUTICALS improved earnings per share more than overall profits. This is good for investors.
This analysis provides a snapshot of SMS PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.